We are live on ! Find out more
MDT icon

Medtronic

86.38 USD
-0.06
0.07%
At close Updated Oct 2, 4:00 PM EDT
Pre-market
After hours
86.60
+0.22
0.25%
1 day
-0.07%
5 days
-2.2%
1 month
-6.29%
3 months
3.83%
6 months
-0.29%
Year to date
-10.07%
1 year
-9.53%
5 years
-30.92%
10 years
-0.01%
 

About: One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, surgical robots, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Employees: 95,000

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 55.1%
Neutral 39.8%
Negative 5.1%
Negative
Barrons
17 hours ago
Why Medtronic's $4 Billion MiniMed Exchange Offer Is Losing Its Allure
The tax-free exchange offer allows Medtronic investors to swap their shares for MiniMed shares held by Medtronic in what Wall Street calls a split-off.
Why Medtronic's $4 Billion MiniMed Exchange Offer Is Losing Its Allure
Positive
The Motley Fool
1 day ago
Kevin Warsh's Inflation Stance Makes These Cheap Dividend Stocks Look a Lot More Attractive
Kevin Warsh has stated that inflation is the Fed's primary target right now. Medtronic has a well-above-market 3.2% yield, and its medical devices aren't optional for most people.
Kevin Warsh's Inflation Stance Makes These Cheap Dividend Stocks Look a Lot More Attractive
Neutral
PRNewsWire
1 day ago
Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems
Coding approvals reflect growing clinical evidence and physician adoption of Medtronic solutions addressing urge urinary incontinence and hypertension  GALWAY, Ireland, Oct. 1, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that the American Medical Association (AMA) approved new Category I Current Procedural Terminology (CPT®) codes for two of its technologies, which represent important long-term growth opportunities for Medtronic: Altaviva™ implantable tibial neuromodulation device for the treatment of urge urinary incontinence and Symplicity Spyral™ renal denervation (RDN) system for the treatment of uncontrolled hypertension. The new codes, which will replace existing Category III codes, are effective January 2028.
Medtronic Receives Category I CPT® Code Approvals for Altaviva™ and Symplicity Spyral™ Systems
Negative
Zacks Investment Research
1 day ago
Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report?
Medtronic (MDT) reported earnings 30 days ago. What's next for the stock?
Why Is Medtronic (MDT) Down 6.4% Since Last Earnings Report?
Positive
The Motley Fool
2 days ago
History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade.
Johnson & Johnson has significantly outperformed Medtronic over the past decade. Much of its outperformance started with its 2021 decision to spin off its consumer healthcare business.
History Says Johnson & Johnson Beats Medtronic. Here's Why I'd Still Consider MDT for the Next Decade.
Positive
Zacks Investment Research
2 days ago
Why Medtronic (MDT) is a Top Value Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Medtronic (MDT) is a Top Value Stock for the Long-Term
Neutral
PRNewsWire
3 days ago
Medtronic announces regulatory milestones for newest cardiac mapping and ablation software
FDA clearance and CE Mark for latest Affera™ Prism-2 Mapping Software expand cardiac mapping capabilities CE Mark for PulseSelect ProxBox™ Adapter with Proximity Indicator software adds real-time tissue proximity feedback GALWAY, Ireland, Sept. 30, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced regulatory milestones for software used with two cardiac ablation platforms.
Medtronic announces regulatory milestones for newest cardiac mapping and ablation software
Neutral
Zacks Investment Research
3 days ago
Medtronic (MDT) Registers a Bigger Fall Than the Market: Important Facts to Note
In the closing of the recent trading day, Medtronic (MDT) stood at $87.09, denoting a -2.69% move from the preceding trading day.
Medtronic (MDT) Registers a Bigger Fall Than the Market: Important Facts to Note
Positive
Zacks Investment Research
3 days ago
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Neutral
24/7 Wall Street
3 days ago
3 Historically Stable Dividend Raisers in Medical Devices Offering Solid Yields With Fortress-Like Growth
Pacemakers and glucose monitors keep selling whether the economy booms or collapses, and three medical device giants have spent decades turning that predictable demand into paychecks that grow every single year.
3 Historically Stable Dividend Raisers in Medical Devices Offering Solid Yields With Fortress-Like Growth
Price charts implemented using Lightweight Charts™